Last reviewed · How we verify
NCT07049042
Hypogonadotrophic Hypogonadism in Genetic Neurodevelopmental Conditions
trial in Genetic Neurodevelopmental Disorders in 50 participants. Currently enrolling.
1 May 2029
Quick facts
| Lead sponsor | University of Sheffield |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 8 January 2025 |
| Primary completion | 1 May 2029 |
| Estimated completion | 1 May 2029 |
| Sites | 1 location across United Kingdom |
Conditions studied
- Genetic Neurodevelopmental Disorders — all drugs for Genetic Neurodevelopmental Disorders →
Sponsor
University of Sheffield
Who can join
Adults 0 to 99, any sex, with Genetic Neurodevelopmental Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Hypogonadism is the medical name for a condition in which levels of the hormones which control sexual development are lower than normal. There are dozens of different causes of hypogonadism. Many people with hypogonadism have a change in a gene. There are many genes that give instructions for the hormones important for sexual development. Changes in one of these genes that stops the gene from working, can cause hypogonadism. In some of these medical conditions, there are additional features such as learning problems. In this study we will search databases to find all the genetic conditions that can be associated with hypogonadism. We will ask a number of people with changes in certain genes, identified from our search, to come to our research clinic. We will ask them about their health and examine them for signs of hypogonadism. For some, we will take blood samples to test for hypogonadism. This project will help us understand how common hypogonadism is, in people with these genetic changes, which will help with their treatment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07049042
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Sheffield trials
Trials by the same sponsor.
- NCT07132879 — Telehealth in MND-Research (TIM-R): A Research Database for MND · recruiting
- NCT06628427 — Unlock the Secrets of Ageing Brains Through P300 Brain-computer Interface Games · not yet recruiting
- NCT06476483 — Feasibility and Acceptability of Implementing DIALOG+ in a Psychiatric Rehabilitation Unit · NA · completed
- NCT06508840 — The Clear Conversations Project · recruiting
- NCT05344326 — Cognitive Analytic-Informed Guided Self-help for Depression · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07049042 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Sheffield
- Last refreshed: 3 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07049042.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing